Rubius Therapeutics Added to Nasdaq Biotechnology Index
CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company developing an entirely new […]
Credit Acceptance Announces Extension of Revolving Secured Warehouse Facility
Southfield, Michigan, Dec. 17, 2018 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, […]
TSX News -
TFI International Declares Quarterly Dividend
MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) — The Board of Directors of TFI International Inc. (TSX: TFII, OTCQX: TFIFF), a […]
Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Trials and Provides Clinical Development Strategy Update
ACH-4471, First Generation Oral factor D Inhibitor– Proof of Concept Validated in both PNH as Monotherapy and in Combination w/C5 […]
OptimizeRx Announces Proposed Public Offering of Common Stock
ROCHESTER, Mich., Dec. 17, 2018 (GLOBE NEWSWIRE) — OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for […]
CareTrust REIT Announces Quarterly Dividend of $0.205 per Share
SAN CLEMENTE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that its Board of Directors […]
Aclaris Therapeutics Provides Update on Oral and Topical JAK 1/3 Inhibitor Clinical Trials
Conference call to be held and accompanying slide deck with photos to be included with Current Report on Form 8-K […]
CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA
BRISBANE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, […]
Jericho Oil Announces Reaffirmation of Borrowing Base and Restructuring of Hedging Program
TULSA, Okla., Dec. 17, 2018 (GLOBE NEWSWIRE) — Jericho Oil Corporation (“Jericho”) (TSX-V: JCO; OTC PINK: JROOF) is pleased to […]
Principia Biopharma Issues Statement About the Passing of Board Member Lewis J. Shuster
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) — Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated […]
